A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Reversible Congenital Hypogonadotropic Hypogonadism in Patients with CHD7, FGFR1 or GNRHR Mutations
Tekijät: Laitinen EM, Tommiska J, Sane T, Vaaralahti K, Toppari J, Raivio T
Kustantaja: PUBLIC LIBRARY SCIENCE
Julkaisuvuosi: 2012
Journal: PLoS ONE
Tietokannassa oleva lehden nimi: PLOS ONE
Lehden akronyymi: PLOS ONE
Artikkelin numero: ARTN e39450
Numero sarjassa: 6
Vuosikerta: 7
Numero: 6
Sivujen määrä: 6
ISSN: 1932-6203
DOI: https://doi.org/10.1371/journal.pone.0039450
Tiivistelmä
Conclusions: Considerable proportion of patients with HH (8% of KS probands) may recover in early adulthood. Spontaneous testicular enlargement during TRT was highly suggestive for reversal of HH. Those with the GNRHR mutation R262Q accompanied by another GNRHR mutation may be prone to reversal, although even patients with a truncating mutation in CHD7 or a splice-site mutation in FGFR1 can recover. We recommend that all adolescents and young adults with congenital HH should be informed on the possibility of reversal.
Conclusions: Considerable proportion of patients with HH (8% of KS probands) may recover in early adulthood. Spontaneous testicular enlargement during TRT was highly suggestive for reversal of HH. Those with the GNRHR mutation R262Q accompanied by another GNRHR mutation may be prone to reversal, although even patients with a truncating mutation in CHD7 or a splice-site mutation in FGFR1 can recover. We recommend that all adolescents and young adults with congenital HH should be informed on the possibility of reversal.
Turun yliopiston Tutkimustietojärjestelmän portaali